Home › Companies › APPLIED THERAPEUTICS INC. › 2024-2025
At APPLIED THERAPEUTICS INC.'s shareholder meeting held June 9, 2025, in the 2024-2025 proxy season, 95 asset managers reported how they voted in their SEC Form N-PX filings, covering 771 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE (ON A NON-BINDING ADVISORY BASIS) THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS… — APPLIED THERAPEUTICS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: APPLIED THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and APPLIED THERAPEUTICS INC.’s Form 8-K, filed June 12, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 9, 2025: 4 items on APPLIED THERAPEUTICS INC.’s Form 8-K, filed June 12, 2025: 3 approved · 1 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025
Explore APPLIED THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are APPLIED THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Teena Lerner, Ph.D. | 44,287,976 | -- | 17,031,078 | -- | 39,277,498 | — | Not verified | — |
| 2. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 99,429,280 | 679,553 | 725,233 | -- | -- | 99.3% | Approved | — |
| Company's stockholders voted to approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials. | 57,650,206 | 3,307,662 | 598,700 | -- | 39,277,498 | 95% | Approved | — |
| Company's stockholders voted to approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to combine the outstanding shares of the Company's common stock, par value $0.0001 per share, into a lesser number of out | 92,238,511 | 8,537,480 | 58,075 | -- | -- | 92% | Approved | — |
Source: APPLIED THERAPEUTICS INC., Form 8-K, filed with the SEC on June 12, 2025 — read the filing on EDGAR.
Each item below shows how the 95 asset managers that disclosed a APPLIED THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of APPLIED THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
98% of fund votes cast · no official result
Description as filed by funds: ELECTION OF DIRECTOR: TEENA LERNER
The 32 asset managers below reported 16,098,685 for, 372,285 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 5,241,335 | 0 | 0 | 0 | For |
| Vanguard | 3,586,619 | 0 | 0 | 0 | For |
| BlackRock | 3,330,945 | 0 | 0 | 0 | For |
| Fidelity | 1,955,009 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 725,000 | 0 | 0 | 0 | For |
| Charles Schwab | 636,357 | 0 | 0 | 0 | For |
| Equitable | 176,048 | 100,840 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 165,898 | 0 | 0 | 0 | For |
| Lincoln Financial | 71,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 62,627 | 0 | 0 | Against |
| Northern Trust | 0 | 58,434 | 0 | 0 | Against |
| Global X | 56,469 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 47,972 | 0 | 0 | Against |
| Pacific Life | 44,164 | 0 | 0 | 0 | For |
| Voya | 0 | 39,060 | 0 | 0 | Against |
| Bridge Builder Trust | 28,657 | 0 | 0 | 0 | For |
| TIAA | 28,563 | 0 | 0 | 0 | For |
| ProShares | 0 | 23,184 | 0 | 0 | Against |
| Nationwide | 17,724 | 0 | 0 | 0 | For |
| SEI | 15,800 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 13,600 | 0 | 0 | Against |
| Calvert | 0 | 9,419 | 0 | 0 | Against |
| Columbia Threadneedle | 7,733 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 6,741 | 0 | 0 | Against |
| DWS | 0 | 6,562 | 0 | 0 | Against |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
92% Approved · of votes cast
Description as filed by funds: To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to combine the outstanding shares of our common stock, par value $0.0001 per share, into a lesser number of outstanding shares, by a ratio of not less than one-for-5 and not more than one-for-40, with the exact ratio to be set within this range by our board of directors in its sole discretion (the "Reverse Stock Split Proposal").
APPLIED THERAPEUTICS INC.’s own tally for this item (“Proposal 5: The Company's stockholders voted to approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to combine the outstanding shares of the Company's common stock, par value $0.000”): 92,238,511 for, 8,537,480 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders voted to approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to combine the outstanding shares of the Company's common stock, par value $0.0001 per share, into a lesser number of outstanding shares, by a ratio of not less than one-fo…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 16,470,970 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 5,241,335 | 0 | 0 | 0 | For |
| Vanguard | 3,586,619 | 0 | 0 | 0 | For |
| BlackRock | 3,330,945 | 0 | 0 | 0 | For |
| Fidelity | 1,955,009 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 725,000 | 0 | 0 | 0 | For |
| Charles Schwab | 636,357 | 0 | 0 | 0 | For |
| Equitable | 276,888 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 165,898 | 0 | 0 | 0 | For |
| Lincoln Financial | 71,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 62,627 | 0 | 0 | 0 | For |
| Northern Trust | 58,434 | 0 | 0 | 0 | For |
| Global X | 56,469 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 47,972 | 0 | 0 | 0 | For |
| Pacific Life | 44,164 | 0 | 0 | 0 | For |
| Voya | 39,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 28,657 | 0 | 0 | 0 | For |
| TIAA | 28,563 | 0 | 0 | 0 | For |
| ProShares | 23,184 | 0 | 0 | 0 | For |
| Nationwide | 17,724 | 0 | 0 | 0 | For |
| SEI | 15,800 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,600 | 0 | 0 | 0 | For |
| Calvert | 9,419 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,733 | 0 | 0 | 0 | For |
| Victory Capital | 6,741 | 0 | 0 | 0 | For |
| DWS | 6,562 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
68% of fund votes cast · no official result
Description as filed by funds: TO AUTHORIZE THE ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES IN FAVOR OF THE REVERSE STOCK SPLIT PROPOSAL.
The 32 asset managers below reported 11,147,271 for, 5,323,699 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 5,241,335 | 0 | 0 | Against |
| Vanguard | 3,586,619 | 0 | 0 | 0 | For |
| BlackRock | 3,330,945 | 0 | 0 | 0 | For |
| Fidelity | 1,955,009 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 725,000 | 0 | 0 | 0 | For |
| Charles Schwab | 636,357 | 0 | 0 | 0 | For |
| Equitable | 276,888 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 165,898 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 71,300 | 0 | 0 | Against |
| Goldman Sachs | 62,627 | 0 | 0 | 0 | For |
| Northern Trust | 58,434 | 0 | 0 | 0 | For |
| Global X | 56,469 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 47,972 | 0 | 0 | 0 | For |
| Pacific Life | 44,164 | 0 | 0 | 0 | For |
| Voya | 39,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 28,657 | 0 | 0 | 0 | For |
| TIAA | 28,563 | 0 | 0 | 0 | For |
| ProShares | 23,184 | 0 | 0 | 0 | For |
| Nationwide | 17,724 | 0 | 0 | 0 | For |
| SEI | 15,800 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,600 | 0 | 0 | 0 | For |
| Calvert | 9,419 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,733 | 0 | 0 | 0 | For |
| Victory Capital | 6,741 | 0 | 0 | 0 | For |
| DWS | 6,562 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: TO APPROVE (ON A NON-BINDING ADVISORY BASIS) THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE ACCOMPANYING MATERIALS.
APPLIED THERAPEUTICS INC.’s own tally for this item (“Proposal 3: The Company's stockholders voted to approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials.”): 57,650,206 for, 3,307,662 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders voted to approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 5,241,335 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 4,487,505 | 0 | 0 | 0 | For |
| Vanguard | 3,586,619 | 0 | 0 | 0 | For |
| BlackRock | 3,330,945 | 0 | 0 | 0 | For |
| Fidelity | 1,955,009 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 725,000 | 0 | 0 | 0 | For |
| Charles Schwab | 636,357 | 0 | 0 | 0 | For |
| Equitable | 276,888 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 165,898 | 0 | 0 | 0 | For |
| Lincoln Financial | 71,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 62,627 | 0 | 0 | Against |
| Northern Trust | 58,434 | 0 | 0 | 0 | For |
| Global X | 56,469 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 47,972 | 0 | 0 | 0 | For |
| Pacific Life | 44,164 | 0 | 0 | 0 | For |
| Voya | 39,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 28,657 | 0 | 0 | 0 | For |
| TIAA | 28,563 | 0 | 0 | 0 | For |
| ProShares | 23,184 | 0 | 0 | 0 | For |
| Nationwide | 17,724 | 0 | 0 | 0 | For |
| SEI | 15,800 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,600 | 0 | 0 | 0 | For |
| Calvert | 0 | 9,419 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 7,733 | 0 | 0 | Against |
| Victory Capital | 6,741 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 20,878,293 for, 80,182 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 9,042,816 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 8,725,941 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 5,360,425 | 0 | 0 | 0 | For |
| BlackRock | 3,743,731 | 1,501 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,199,809 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 2,074,891 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,988,138 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,490,414 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 1,307,381 | 0 | 0 | 0 | For |
| State Street | 977,753 | 790 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 860,000 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 844,355 | 0 | 0 | Against |
| Charles Schwab | 636,357 | 0 | 0 | 0 | For |
| Birchview Capital, LP | 480,080 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 443,600 | 0 | 0 | 0 | For |
| AQR | 408,483 | 0 | 0 | 0 | For |
| Northern Trust | 375,353 | 0 | 0 | 0 | For |
| Two Sigma | 226,452 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 140,616 | 0 | 0 | 0 | For |
| Vanguard | 115,901 | 0 | 0 | 0 | For |
| AllianceBernstein | 100,840 | 0 | 0 | 0 | For |
| Rhumbline | 34,314 | 45 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 46,287 | 0 | 0 | Against |
| JPMorgan | 44,313 | 0 | 0 | 0 | For |
| Invesco | 0 | 39,520 | 0 | 0 | Against |
Institutional-manager reports, all 75 managers: 41,039,370 for, 1,003,939 against, 34,359 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.8% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: TO APPROVE (ON A NON-BINDING ADVISORY BASIS) THE FREQUENCY OF AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS IN FUTURE YEARS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | -- |
| Calvert | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 32 managers: 16,470,970 1 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Vestal Point Capital, LP | 0 | 0 | 0 | 0 | -- |
| VR Adviser, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Rock Springs Capital Management LP | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Alyeska Investment Group, L.P. | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Birchview Capital, LP | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| ROCKEFELLER FINANCIAL LLC | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 34,314 | 45 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 70 managers: 34,314 for, 45 against, 39,599,855 1 year, 568 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.3% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR 2025.
APPLIED THERAPEUTICS INC.’s own tally for this item (“2. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 99,429,280 for, 679,553 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 33 asset managers below reported 20,958,475 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 5,241,335 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 4,487,505 | 0 | 0 | 0 | For |
| Vanguard | 3,586,619 | 0 | 0 | 0 | For |
| BlackRock | 3,330,945 | 0 | 0 | 0 | For |
| Fidelity | 1,955,009 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 725,000 | 0 | 0 | 0 | For |
| Charles Schwab | 636,357 | 0 | 0 | 0 | For |
| Equitable | 276,888 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 165,898 | 0 | 0 | 0 | For |
| Lincoln Financial | 71,300 | 0 | 0 | 0 | For |
| Goldman Sachs | 62,627 | 0 | 0 | 0 | For |
| Northern Trust | 58,434 | 0 | 0 | 0 | For |
| Global X | 56,469 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 47,972 | 0 | 0 | 0 | For |
| Pacific Life | 44,164 | 0 | 0 | 0 | For |
| Voya | 39,060 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 28,657 | 0 | 0 | 0 | For |
| TIAA | 28,563 | 0 | 0 | 0 | For |
| ProShares | 23,184 | 0 | 0 | 0 | For |
| Nationwide | 17,724 | 0 | 0 | 0 | For |
| SEI | 15,800 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 13,600 | 0 | 0 | 0 | For |
| Calvert | 9,419 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,733 | 0 | 0 | 0 | For |
| Victory Capital | 6,741 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. All 33 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 141,575,526 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 3.70% |
| 2 | Simplify Exchange Traded Funds | 3.17% |
| 3 | Vanguard | 2.53% |
| 4 | BlackRock | 2.35% |
| 5 | Fidelity | 1.38% |
| 6 | FRANKLIN STRATEGIC SERIES | 0.51% |
| 7 | Charles Schwab | 0.45% |
| 8 | Equitable | 0.20% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.12% |
| 10 | Lincoln Financial | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 6.39% |
| 2 | Vestal Point Capital, LP | 6.16% |
| 3 | VR Adviser, LLC | 3.79% |
| 4 | BlackRock | 2.65% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.55% |
| 6 | Rock Springs Capital Management LP | 1.47% |
| 7 | FRANKLIN ADVISERS INC | 1.40% |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.05% |
| 9 | MARSHALL WACE, LLP | 0.92% |
| 10 | State Street | 0.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 15.12% | 13G |
| Entities affiliated with Alexandria Real Estate Equities, Inc. | 8.87% | DEF14A |
| Entities affiliated with Venrock Healthcare Capital Partners III, L.P. | 8.34% | DEF14A |
| Entities affiliated with Vestal Point Capital, LP | 8.12% | DEF14A |
| BlackRock | 6.75% | 13F |
| Entities affiliated with Blackrock, Inc. | 6.57% | DEF14A |
| Entities affiliated with Schonfeld Strategic Advisors LLC | 6.19% | DEF14A |
| Entities affiliated with Propel Bio Management, LLC | 5.70% | DEF14A |
| Alyeska Investment Group, L.P. | 4.74% | 13G |
| Alexandria Real Estate Equities, Inc. | 4.59% | 13G |
Percentages above are of 141,575,526 shares outstanding, as reported by APPLIED THERAPEUTICS INC. on its Form 10-Q dated May 12, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from APPLIED THERAPEUTICS INC.’s 10-Q dated May 12, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
APPLIED THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page).
proxyvotesnow.com, “APPLIED THERAPEUTICS INC. 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/applied-therapeutics-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.